Comparison of Candesartan Versus Metoprolol for Treatment of Systemic Hypertension After Repaired Aortic Coarctation

American Journal of Cardiology

Volumn 105, Issue 2, 2010, Pages 217-222

  Moltzer, Els ^a   Mattace Raso, Francesco U S ^a   Karamermer, Yusuf ^a   Boersma, Eric ^a   Webb, Gary D ^b   Simoons, Maarten L ^a   Danser, A H Jan ^a   van den Meiracker, Anton H ^a   Roos Hesselink, Jolien W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; CATECHOLAMINE; ENDOTHELIN 1; METOPROLOL; METOPROLOL TARTRATE; NEUROHORMONE; NORADRENALIN; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE ACTIVITY; AORTA COARCTATION; AORTA SURGERY; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COLD SENSATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFECT; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; LEG PAIN; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PLASMA RENIN ACTIVITY; PRESSURE SENSATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATORY DISTRESS; SIDE EFFECT; SLEEP DISORDER; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AORTIC COARCTATION; BENZIMIDAZOLES; COHORT STUDIES; CROSS-OVER STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED; PEPTIDE HORMONES; TETRAZOLES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73149118306     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.674     Document Type: Article

References (22)

1. Vriend J.W., and Mulder B.J. Late complications in patients after repair of aortic coarctation: implications for management. Int J Cardiol 101 (2005) 399-406
2. O'Sullivan J.J., Derrick G., and Darnell R. Prevalence of hypertension in children after early repair of coarctation of the aorta: a cohort study using casual and 24 hour blood pressure measurement. Heart 88 (2002) 163-166
3. Presbitero P., Demarie D., Villani M., Perinetto E.A., Riva G., Orzan F., Bobbio M., Morea M., and Brusca A. Long term results (15-30 years) of surgical repair of aortic coarctation. Br Heart J 57 (1987) 462-467
4. Gardiner H.M., Celermajer D.S., Sorensen K.E., Georgakopoulos D., Robinson J., Thomas O., and Deanfield J.E. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation 89 (1994) 1745-1750
5. Sehested J., Baandrup U., and Mikkelsen E. Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation. Implications for baroreceptor function. Circulation 65 (1982) 1060-1065
6. Gidding S.S., Rocchini A.P., Moorehead C., Schork M.A., and Rosenthal A. Increased forearm vascular reactivity in patients with hypertension after repair of coarctation. Circulation 71 (1985) 495-499
7. Swan L., Ashrafian H., and Gatzoulis M.A. Repair of coarctation: a higher goal?. Lancet 359 (2002) 977-978
8. Beekman R.H., Katz B.P., Moorehead-Steffens C., and Rocchini A.P. Altered baroreceptor function in children with systolic hypertension after coarctation repair. Am J Cardiol 52 (1983) 112-117
9. Mattace-Raso F.U., van den Meiracker A.H., Bos W.J., van der Cammen T.J., Westerhof B.E., Elias-Smale S., Reneman R.S., Hoeks A.P., Hofman A., and Witteman J.C. Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam study. J Hypertens 25 (2007) 1421-1426
10. Mahmud A., and Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 1 (2003) 65-78
11. Klemsdal T.O., Moan A., and Kjeldsen S.E. Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension. Blood Press 8 (1999) 214-219
12. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., Ducimetiere P., and Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
13. Hoeks A.P., Brands P.J., Smeets F.A., and Reneman R.S. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 16 (1990) 121-128
14. Reneman R.S., van Merode T., Hick P., Muytjens A.M., and Hoeks A.P. Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol 12 (1986) 465-471
15. van den Meiracker A.H., Lameris T.W., van de Ven L.L., and Boomsma F. Increased plasma concentration of natriuretic peptides by selective beta1-blocker bisoprolol. J Cardiovasc Pharmacol 42 (2003) 462-468
16. Smits P., Hofman H., Rosmalen F., Wollersheim H., and Thien T. Endothelin-1 in patients with Raynaud's phenomenon. Lancet 337 (1991) 236
17. van der Hoorn F.A., Boomsma F., Man in 't Veld A.J., and Schalekamp M.A. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 487 (1989) 17-28
18. Lam Y.Y., Mullen M.J., Kaya M.G., Gatzoulis M.A., Li W., and Henein M.Y. Left ventricular long axis dysfunction in adults with "corrected" aortic coarctation is related to an older age at intervention and increased aortic stiffness. Heart 95 (2009) 733-739
19. Henein M.Y., and Gibson D.G. Long axis function in disease. Heart 81 (1999) 229-231
20. van Kats J.P., Duncker D.J., Haitsma D.B., Schuijt M.P., Niebuur R., Stubenitsky R., Boomsma F., Schalekamp M.A., Verdouw P.D., and Danser A.H. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102 (2000) 1556-1563
21. Gironacci M.M., Adler-Graschinsky E., Pena C., and Enero M.A. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria. Hypertension 24 (1994) 457-460
22. Maruyama R., Hatta E., Yasuda K., Smith N.C., and Levi R. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors. J Pharmacol Exp Ther 294 (2000) 248-254